United Therapeutics Financial Ratios
UTHR / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
18.8%
ROE ranks in the above average among Health Care companies
Profit Margin
41.9%
Net Income / Revenue
Asset Turnover
0.40
Revenue / Total Assets
Equity Multiplier
1.11
Total Assets / Equity
Composite: 18.8% (reported: 18.8%)
Profitability
Liquidity
Current Ratio
6.60
Quick Ratio
6.28
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.40
Inventory Turnover
2.10
Days Sales Outstanding
40 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
-3.0%
-1.2pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.